Cite
HARVARD Citation
Mathiesen, E. et al. (2023). Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial. Lancet. 11 (2), pp. 86-95. [Online].